Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of ProNGF
US9061045B2 · kind B2 · utility
9Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 26, 2012 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Dec 5, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A ProNGF inhibitor for preparing a drug, said drug being in particular useful for blocking remote dissemination and cell invasion in patients suffering from cancer, in particular breast, thyroid or lung cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.